Finally, my warmest thanks to the CRICS-TriggerSep Scientific Board for their crucial role in designing and conducting this trial.
https://www.nejm.org/doi/full/10.1056/NEJMoa2502136
#EVERDAC #CriticalCare #ESICM2025 #NEJM #ICU #Research #CRICSTriggerSep
In patients with shock, whether noninvasive blood-pressure monitoring is an effective alternative to the recommended use of an arterial catheter is uncertain. In this multicenter, open-label, nonin...
Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, doubl...
Update. Three past editors of the New England Journal of Medicine (#NEJM) answer the attack on their journal from #RFKJr.
https://www.statnews.com/2025/06/30/rfk-jr-medical-journals-nejm-jama-lancet-editors-respond-medical-journals-ethics/
(#paywalled)
"Kennedy claimed that one of us (Angell) said, 'We are no longer a science journal, we are a vessel for pharmaceutical propaganda.' In fact, what Angell said in a 2009 article was that 'it is simply no longer possible to believe much of the clinical research that is published,' due to researchers’ financial ties with pharmaceutical companies."
The editors also point out that the three journals named by Kennedy happen to have published editorials criticizing the #Trump admin assault of science.
#DefendResearch #Medicine #Pharma #ScholComm #TrumpVResearch #USPol #USPolitics